ContextVision AB (publ) (OB: CONTX)
Health Care · Health Care Technology · SE
Nkr4.88
-2.20% today · +4.8% 1Y
ContextVision AB (publ) (OB: CONTX) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $38.86M and employs 39 people.
Over the last twelve months the share price has gained 4.8%, trading between 2.70 and 5.78.
Tweenvest scores ContextVision AB (publ) across four factors: quality 83/100, value 40/100, growth 15/100. Its strongest factor is quality.
CONTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $38.86M
- Revenue (TTM)
- $12.30M
- P/E
- 27.90
- EPS
- 0.18
- Dividend yield
- —
- Beta (5Y)
- 0.12
- 52-week high
- Nkr5.78
- 52-week low
- Nkr2.70
- Avg volume (3M)
- —
- Shares outstanding
- 74.51M
- Employees
- 39
- Next earnings
- —
About ContextVision AB (publ)
ContextVision AB (publ), a medical technology enterprise established in Stockholm, Sweden, in 1983, delivers sophisticated software solutions. The firm specializes in image analysis and artificial intelligence, supplying these advanced technologies to original equipment manufacturers (OEMs) across Asia, Europe, and the United States. Their comprehensive product suite is designed to optimize image quality across various medical imaging modalities, including two-dimensional, three-dimensional, and four-dimensional ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Key offerings include: Rivent: Provides superior image quality for a broad spectrum of ultrasound applications such as women's health, general imaging, cardiovascular, and point-of-care. VolarView: An image enhancement software specifically developed for the burgeoning handheld ultrasound market. GOPiCE: A proprietary technology enabling real-time volumetric image enhancement. Altumira/Altumira Plus: A robust platform for digital radiography. An Orthopedic Package: Tailored for specialized orthopedic imaging needs. GOPView MRI2Plus: An advanced solution for MRI image improvement. INIFY Prostate Screening: Offers digital analysis for prostate biopsies.
- ISIN
- SE0014731154
- Founded
- 1989
- Listed since
- Jan 3, 2000
- Exchange
- Oslo Bors
- Currency
- NOK
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| DIAGNOS Inc.TSXV: ADK | $40.57M | CA$0.47 | -3.12% |
| Rocket Doctor AI Inc.CNSX: AIDR | $39.63M | CA$0.57 | -3.39% |
| GuideAI Health Corp.DB: ZN0 | $39.41M | €0.62 | -7.36% |
| Aiforia Technologies OyjHLSE: AIFORIA | $38.92M | €0.90 | -3.12% |
| Singular Health Group LtdASX: SHG | $37.55M | AU$0.17 | -10.81% |
| CJ Bioscience, Inc.KOSDAQ: A311690 | $37.37M | ₩3,845.00 | +1.85% |
| Mach7 Technologies LimitedASX: M7T | $35.26M | AU$0.22 | -6.52% |
| Reliq Health Technologies Inc.TSXV: RHT.H | $35.14M | CA$— | — |
Figures last refreshed Oct 11, 2026.